Infected Blood Inquiry

Read the latest news on the Public
Inquiry into Contaminated Blood

The taintedblood Timeline  -  what really happened...

"To no one will we sell, to no one deny or delay, right or justice."
Magna Carta - 15th June, 1215

 
No of entries selected: 6 of 711
1980
Dr. Edward Shanbrom - Solvent Detergent Patent
Dr. Edward Shanbrom, a former Baxter scientist, receives a patent for a solvent detergent treatment process for viral inactivation of factor concentrate. He approaches all 4 US pharmaceuticals about implementing the solvent detergent method, however all 4 companies refuse to implement the method.

Dr. Shanbrom describes the implementation of this process to be "as easy as washing your hands."

Source: (Factual Allegations by U.S. Hemophilia Victims, paragraph 2)
Link #2
Additional Source: Douglas Starr:
Type: Patent Solvent Detergent Process
Location: USA
Find related entries
1982
14 October
Factor VIII Study Group - Early Detergent Tests
Early tests are being conducted in the use of detergents to purify factor VIII. The minutes of a meeting of the SNBTS Factor VIII Study Group suggest that not only is the use of detergents possible in late 1982, but also that the process is a valid proposition: "Practically all of the detergents tested so far had proved quite successful, with a good survival rate of FVIII:C."

Note: Despite Dr. Edward Shanbrom patenting and proposing the process to US industry in 1980, solvent detergents are not widely taken up by the leading pharmaceutical companies until 1987.

Source: Link #1
Type: Meeting Minutes - Detergent Tests
Location: Scotland
Find related entries
1985
June
New York Blood Center (NYBC) - Solvent Detergent License Obtained from FDA
The New York Blood Center ("NYBC") obtains a license from the FDA to implement the solvent detergent process for manufacture of Factor VIII.
Source: Report of the Tribunal of Inquiry: Lindsay Final
Link #2
Type: FDA License
Location: USA
Find related entries
1987
Cutter, Alpha, Baxter - Detergent Process - Delayed Implementation
CUTTER, ALPHA and BAXTER are now using the solvent detergent process to virally inactivate their Factor VIII blood products.

Note: 7 years earlier, all four US plasma companies were approached by Dr. Edward Shanbrom, who presented his solvent detergent treatment process. Sadly, all 4 companies declined his process and as a result countless hemophiliacs' lives were lost.

Source: First Amended CLASS ACTION COMPLAINT (2004) Case No. C032572 PJH. Pages 20-21.
Type: Development - Solvent Detergent Process
Location: USA
Find related entries
1987
Armour - Solvent Detergent Process
Armour is still not using the solvent detergent process to virally inactivate their Factor VIII blood products.
Source: First Amended Class Action Complaint (2004) Case No. C032572 PJH. Page 21.
Type: Development
Location: USA
Find related entries
1988
Hyland - Solvent Detergent
In 1988, Hyland, was the first commercial manufacturer of Factor VIII in the USA to make concentrate using the solvent detergent process which is also purified by monoclonal antibody technology.
Source: Link #1
Report of the Tribunal of Inquiry: Lindsay Final, page 95:
Link #3
Type: Solvent Detergent Development
Location: USA
Find related entries
Timeline Copyright ©2006 Andrew March & Haydn Lewis
All rights reserved

 

Telephone

07717471460

Follow

Address

7 Yessell Lane, Hinton-on-the-Green, Evesham, Worcestershire WR11 2RE

Terms & Conditions | Privacy | Website © Tainted Blood 2021